News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
News Conference News EuroPCR 2017 EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40 Shelley Wood May 12, 2017
News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Daily News Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions L.A. McKeown March 02, 2017
News Daily News DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed Michael O'Riordan February 16, 2017
Presentation JIM 2017 FORTITUDE, APTITUDE and MAGNITUDE: Other Thin-Strut Novel PLLA-Based Scaffolds Presenter: Azeem Latib February 08, 2017
Presentation JIM 2017 DESolve: A Family of Novel PLLA-Based Scaffolds Presenter: Martin B. Leon February 08, 2017
News Industry News FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery January 30, 2017
News Daily News Tricky Population of Patients With A-fib Undergoing PCI Tackled in New Consensus Document Todd Neale November 29, 2016
News Conference News TCT 2016 Novel SES Fails to Match Xience EES for Chronic Total Occlusions Yael L. Maxwell November 08, 2016
News Industry News Positive Five-Year Clinical Data from Micell Technologies’ MiStent Presented at TCT 2016 November 03, 2016
News Industry News TCT 2016 Imaging Study Shows Rate of Strut Coverage and Low Rates of Neouatherosclerosis with Thin Strut Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents November 02, 2016
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
Presentation TCT 2016 RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso November 02, 2016
Presentation TCT 2016 TRANSFORM-OCT: A Prospective, Randomized Trial Using OCT Imaging to Evaluate Strut Coverage at Three Months and Neoatherosclerosis at Eighteen Months in Bioresorbable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents Presenter: Gary S. Mintz, Robert-Jan van Geuns, Giulio Guagliumi November 02, 2016
Presentation TCT 2016 TOSCA-5: A Prospective, Randomized Trial Evaluating Collagenase Infusion in Patients With Coronary Artery Chronic Total Occlusions Presenter: Gary S. Mintz, Robert-Jan van Geuns, Christopher E. Buller November 02, 2016
Presentation TCT 2016 PRISON IV: A Prospective, Randomized Trial of a Bioresorbable Polymer-Based Sirolimus-Eluting Stent and a Durable Polymer-Based Everolimus-Eluting Stent in Patients With Coronary Artery Chronic Total Occlusions Presenter: Gary S. Mintz, Robert-Jan van Geuns, Koen Teeuwen November 02, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
Presentation TCT 2016 PLATINUM DIVERSITY: Outcomes From a Large-Scale, Prospective Registry of Coronary Artery Stent Implantation in Women and Minorities Presenter: Howard C. Herrmann, Robert J. de Winter, Wayne B. Batchelor November 01, 2016